| Report ID | 279869 |
| Drug Identification Number | 02410257 |
| Brand name | MIRVALA 28 |
| Common or Proper name | MIRVALA |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DESOGESTREL ETHINYL ESTRADIOL |
| Strength(s) | 0.1500MG 0.0300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 28 BLS |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-03-03 |
| Estimated end date | 2026-03-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-05 | French | Compare |
| v1 | 2026-03-05 | English | Compare |
Showing 1 to 2 of 2